- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 16.78M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 16.78K sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 15.36K sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $14.99M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $16.43M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.12M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.62M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.4M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.94M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $16.26M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $17.69M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $16.97M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $18.38M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.10 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.14 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $196K |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $364K |
| Revenue | Q1 2025 · Mar 31, 2025 | $513K |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $814K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.92M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $15.05M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $17.16M |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.14 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $895K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.08M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.89M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $797K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $17K |